Edges in Network
| Network | GSE11121_egf1520 - GSE11121 - SiGN-BN HC+Bootstrap |
| Network Description | The humoral immune system has a key prognostic impact in node-negative breast cancer |
| Node | SPRY2 |
| Upstream (Parents) |
|---|
| (<<) CAV1 → SPRY2 |
| (<<) CRYAB → SPRY2 |
| (<<) GNG11 → SPRY2 |
| (<<) HS2ST1 → SPRY2 |
| (<<) KCTD12 → SPRY2 |
| (<<) KRT14 → SPRY2 |
| (<<) KRT5 → SPRY2 |
| (<<) PPAP2A → SPRY2 |
| (<<) SLC6A14 → SPRY2 |
| (<<) TNXB → SPRY2 |
| Downstream (Children) |
|---|
| SPRY2 → ADRBK2 (>>) |
| SPRY2 → ALDOA (>>) |
| SPRY2 → ARSJ (>>) |
| SPRY2 → BRCA1 (>>) |
| SPRY2 → CHST3 (>>) |
| SPRY2 → CXCL2 (>>) |
| SPRY2 → DUSP6 (>>) |
| SPRY2 → EGFR (>>) |
| SPRY2 → FGF1 (>>) |
| SPRY2 → FGF7 (>>) |
| SPRY2 → FZD7 (>>) |
| SPRY2 → GNAI1 (>>) |
| SPRY2 → GPR153 (>>) |
| SPRY2 → GULP1 (>>) |
| SPRY2 → ITGA7 (>>) |
| SPRY2 → JAK1 (>>) |
| SPRY2 → MYL9 (>>) |
| SPRY2 → MYLK (>>) |
| SPRY2 → N4BP3 (>>) |
| SPRY2 → NGFR (>>) |
| SPRY2 → NUPR1 (>>) |
| SPRY2 → OVOL1 (>>) |
| SPRY2 → PRKACA (>>) |
| SPRY2 → PRNP (>>) |
| SPRY2 → PTGER4 (>>) |
| SPRY2 → PTGS2 (>>) |
| SPRY2 → PYGL (>>) |
| SPRY2 → RBM7 (>>) |
| SPRY2 → RDH16 (>>) |
| SPRY2 → RND3 (>>) |
| SPRY2 → SOCS5 (>>) |
| SPRY2 → TIMP1 (>>) |
| SPRY2 → TRAF2 (>>) |
